Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine

[1]  A. Kaumann,et al.  Allosteric properties of the 5-HT2 receptor system of the rat tail artery , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  A. Kaumann,et al.  Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  A. Kaumann.  Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  A. Kaumann,et al.  3H-(−)-Bupranolol, a new β-adrenoceptor radioligand: Characterization of its binding to kitten heart β-adrenoceptors , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  A. Kaumann,et al.  A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  G. Martin,et al.  Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants , 1985, British journal of pharmacology.

[7]  S. Maayani,et al.  5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs. , 1985, The Journal of pharmacology and experimental therapeutics.

[8]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[9]  J. V. van Beek,et al.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. , 1981, The Journal of pharmacology and experimental therapeutics.

[10]  J. Leysen,et al.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. , 1981, Life sciences.

[11]  R. Furchgott,et al.  COMPARISON OF DISSOCIATION CONSTANTS AND OF RELATIVE EFFICACIES OF SELECTED AGONISTS ACTING ON PARASYMPATHETIC RECEPTORS * , 1967 .

[12]  J. R. Blinks.  Convenient apparatus for recording contractions of isolated heart muscle. , 1965, Journal of applied physiology.

[13]  R. Furchgott.  Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. , 1954, The Journal of pharmacology and experimental therapeutics.